446 related articles for article (PubMed ID: 14715520)
1. Protection from ischemic liver injury by activation of A2A adenosine receptors during reperfusion: inhibition of chemokine induction.
Day YJ; Marshall MA; Huang L; McDuffie MJ; Okusa MD; Linden J
Am J Physiol Gastrointest Liver Physiol; 2004 Feb; 286(2):G285-93. PubMed ID: 14715520
[TBL] [Abstract][Full Text] [Related]
2. Mouse spinal cord compression injury is reduced by either activation of the adenosine A2A receptor on bone marrow-derived cells or deletion of the A2A receptor on non-bone marrow-derived cells.
Li Y; Oskouian RJ; Day YJ; Rieger JM; Liu L; Kern JA; Linden J
Neuroscience; 2006 Sep; 141(4):2029-39. PubMed ID: 16777350
[TBL] [Abstract][Full Text] [Related]
3. A2A adenosine receptors on bone marrow-derived cells protect liver from ischemia-reperfusion injury.
Day YJ; Li Y; Rieger JM; Ramos SI; Okusa MD; Linden J
J Immunol; 2005 Apr; 174(8):5040-6. PubMed ID: 15814735
[TBL] [Abstract][Full Text] [Related]
4. A2A adenosine receptor activation improves survival in mouse models of endotoxemia and sepsis.
Sullivan GW; Fang G; Linden J; Scheld WM
J Infect Dis; 2004 May; 189(10):1897-904. PubMed ID: 15122527
[TBL] [Abstract][Full Text] [Related]
5. Adenosine and selective A(2A) receptor agonists reduce ischemia/reperfusion injury of rat liver mainly by inhibiting leukocyte activation.
Harada N; Okajima K; Murakami K; Usune S; Sato C; Ohshima K; Katsuragi T
J Pharmacol Exp Ther; 2000 Sep; 294(3):1034-42. PubMed ID: 10945856
[TBL] [Abstract][Full Text] [Related]
6. Renal ischemia-reperfusion injury and adenosine 2A receptor-mediated tissue protection: role of macrophages.
Day YJ; Huang L; Ye H; Linden J; Okusa MD
Am J Physiol Renal Physiol; 2005 Apr; 288(4):F722-31. PubMed ID: 15561971
[TBL] [Abstract][Full Text] [Related]
7. A2A adenosine receptor induction inhibits IFN-gamma production in murine CD4+ T cells.
Lappas CM; Rieger JM; Linden J
J Immunol; 2005 Jan; 174(2):1073-80. PubMed ID: 15634932
[TBL] [Abstract][Full Text] [Related]
8. Adenosine A2A receptor activation reduces hepatic ischemia reperfusion injury by inhibiting CD1d-dependent NKT cell activation.
Lappas CM; Day YJ; Marshall MA; Engelhard VH; Linden J
J Exp Med; 2006 Nov; 203(12):2639-48. PubMed ID: 17088433
[TBL] [Abstract][Full Text] [Related]
9. Adenosine A2A receptor agonist improves cardiac dysfunction from pulmonary ischemia-reperfusion injury.
Reece TB; Laubach VE; Tribble CG; Maxey TS; Ellman PI; Warren PS; Schulman AM; Linden J; Kern JA; Kron IL
Ann Thorac Surg; 2005 Apr; 79(4):1189-95. PubMed ID: 15797048
[TBL] [Abstract][Full Text] [Related]
10. Attenuation of reperfusion lung injury and apoptosis by A2A adenosine receptor activation is associated with modulation of Bcl-2 and Bax expression and activation of extracellular signal-regulated kinases.
Rivo J; Zeira E; Galun E; Einav S; Linden J; Matot I
Shock; 2007 Mar; 27(3):266-73. PubMed ID: 17304107
[TBL] [Abstract][Full Text] [Related]
11. Lipopolysaccharide rapidly modifies adenosine receptor transcripts in murine and human macrophages: role of NF-kappaB in A(2A) adenosine receptor induction.
Murphree LJ; Sullivan GW; Marshall MA; Linden J
Biochem J; 2005 Nov; 391(Pt 3):575-80. PubMed ID: 16022683
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of Kupffer cells reduced CXC chemokine production and liver injury.
Mosher B; Dean R; Harkema J; Remick D; Palma J; Crockett E
J Surg Res; 2001 Aug; 99(2):201-10. PubMed ID: 11469888
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-1-dependent sequential chemokine expression and inflammatory cell infiltration in ischemia-reperfusion injury.
Furuichi K; Wada T; Iwata Y; Kokubo S; Hara A; Yamahana J; Sugaya T; Iwakura Y; Matsushima K; Asano M; Yokoyama H; Kaneko S
Crit Care Med; 2006 Sep; 34(9):2447-55. PubMed ID: 16849996
[TBL] [Abstract][Full Text] [Related]
14. Enhanced pulmonary expression of CXC chemokines during hepatic ischemia/reperfusion-induced lung injury in mice.
Yoshidome H; Lentsch AB; Cheadle WG; Miller FN; Edwards MJ
J Surg Res; 1999 Jan; 81(1):33-7. PubMed ID: 9889054
[TBL] [Abstract][Full Text] [Related]
15. A selective adenosine A2A receptor agonist, ATL-146e, prevents concanavalin A-induced acute liver injury in mice.
Odashima M; Otaka M; Jin M; Horikawa Y; Matsuhashi T; Ohba R; Linden J; Watanabe S
Biochem Biophys Res Commun; 2006 Sep; 347(4):949-54. PubMed ID: 16859640
[TBL] [Abstract][Full Text] [Related]
16. Endogenous A1 adenosine receptors protect against hepatic ischemia reperfusion injury in mice.
Kim J; Kim M; Song JH; Lee HT
Liver Transpl; 2008 Jun; 14(6):845-54. PubMed ID: 18324658
[TBL] [Abstract][Full Text] [Related]
17. Functional and cytoarchitectural spinal cord protection by ATL-146e after ischemia/reperfusion is mediated by adenosine receptor agonism.
Reece TB; Kron IL; Okonkwo DO; Laurent JJ; Tache-Leon C; Maxey TS; Ellman PI; Linden J; Tribble CG; Kern JA
J Vasc Surg; 2006 Aug; 44(2):392-7. PubMed ID: 16890874
[TBL] [Abstract][Full Text] [Related]
18. Diannexin, a novel annexin V homodimer, provides prolonged protection against hepatic ischemia-reperfusion injury in mice.
Teoh NC; Ito Y; Field J; Bethea NW; Amr D; McCuskey MK; McCuskey RS; Farrell GC; Allison AC
Gastroenterology; 2007 Aug; 133(2):632-46. PubMed ID: 17681182
[TBL] [Abstract][Full Text] [Related]
19. Interleukin 18 causes hepatic ischemia/reperfusion injury by suppressing anti-inflammatory cytokine expression in mice.
Takeuchi D; Yoshidome H; Kato A; Ito H; Kimura F; Shimizu H; Ohtsuka M; Morita Y; Miyazaki M
Hepatology; 2004 Mar; 39(3):699-710. PubMed ID: 14999688
[TBL] [Abstract][Full Text] [Related]
20. Endogenous IL-13 protects hepatocytes and vascular endothelial cells during ischemia/reperfusion injury.
Kato A; Okaya T; Lentsch AB
Hepatology; 2003 Feb; 37(2):304-12. PubMed ID: 12540780
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
